HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colin Reisner Selected Research

Suspensions

6/2021Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
1/2021Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease.
1/2020Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD.
1/2020Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
1/2020Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.
10/2019A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
1/2019Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.
1/2019Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD.
12/2018Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects.
10/2018Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Colin Reisner Research Topics

Disease

44Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2003
8Asthma (Bronchial Asthma)
01/2022 - 03/2005
2Obstructive Lung Diseases (Obstructive Lung Disease)
01/2021 - 07/2014
2Chronic Bronchitis
11/2018 - 01/2016
1Pneumonia (Pneumonitis)
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Dyspnea (Shortness of Breath)
01/2019
1Nasopharyngitis
10/2018
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2018
1Peripheral Arterial Disease
01/2018
1Allergic Rhinitis
03/2005
1Seasonal Allergic Rhinitis (Hay Fever)
03/2005
1Inflammation (Inflammations)
03/2005
1Eosinophilia
03/2005
1Perennial Allergic Rhinitis
03/2005
1Ventricular Tachycardia
06/2003
1Tachycardia (Tachyarrhythmias)
06/2003

Drug/Important Bio-Agent (IBA)

31Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2022 - 07/2014
29Formoterol Fumarate (Oxis)FDA Link
01/2021 - 09/2014
24SuspensionsIBA
06/2021 - 11/2016
11Muscarinic AntagonistsIBA
01/2021 - 01/2016
9Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 09/2003
6Tiotropium Bromide (Spiriva)FDA Link
01/2022 - 07/2014
6budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA
01/2021 - 10/2018
6Budesonide (Pulmicort)FDA LinkGeneric
01/2021 - 01/2018
6Bronchodilator Agents (Bronchodilators)IBA
05/2020 - 07/2014
32- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA
05/2020 - 01/2018
3Salmeterol Xinafoate (Serevent)FDA Link
01/2018 - 06/2003
3Omalizumab (Xolair)FDA Link
11/2006 - 03/2005
2aclidinium bromideIBA
01/2019 - 01/2018
2omega-Chloroacetophenone (Mace)IBA
01/2019 - 01/2018
2RoflumilastIBA
11/2018 - 01/2016
2Immunoglobulin E (IgE)IBA
11/2006 - 03/2005
2anti-IgE antibodiesIBA
07/2006 - 03/2005
1Albuterol (Salbutamol)FDA LinkGeneric
06/2021
1GlucocorticoidsIBA
01/2020
1GoldIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1N 30IBA
10/2018
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
01/2018
1LeukotrienesIBA
07/2006
1Monoclonal AntibodiesIBA
07/2006
1AllergensIBA
03/2005
1Fluticasone (Cutivate)FDA LinkGeneric
09/2003
1Adrenergic Agents (Adrenergic Drugs)IBA
06/2003

Therapy/Procedure

36Metered Dose Inhalers (Metered Dose Inhaler)
01/2022 - 07/2014
14Therapeutics
01/2022 - 03/2005
5Dry Powder Inhalers
01/2018 - 01/2016
3Nebulizers and Vaporizers (Inhaler)
01/2021 - 09/2003
1Inhalation Spacers
01/2018
1Respiratory Therapy (Therapy, Respiratory)
01/2016